Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a

Nomegestrol acetate (NOMAC) has been successfully used for the treatment of some gynecological disorders, and as a combined oral contraceptive with approval in many countries. In this study, we investigated the effects of NOMAC on human endometrial cancer cells in vitro and in vivo. The proliferatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, A-ying, Xie, Shu-wu, Zhou, Jie-yun, Zhu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535830/
https://www.ncbi.nlm.nih.gov/pubmed/28640224
http://dx.doi.org/10.3390/ijms18071337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535830/
https://www.ncbi.nlm.nih.gov/pubmed/28640224
http://dx.doi.org/10.3390/ijms18071337

Ejemplares similares